Visually mapping avian flu may help H1N1
UPI - Tue Nov 17, 3:48 pm ETCOLUMBUS, Ohio, Nov. 17 (UPI) -- U.S. researchers linked several powerful computer systems to analyze enormous amounts of genetic data on the H5N1 virus, also known as avian flu.
134 Stories, most recent news story added Fri Nov 20, 6:15 pm ET
COLUMBUS, Ohio, Nov. 17 (UPI) -- U.S. researchers linked several powerful computer systems to analyze enormous amounts of genetic data on the H5N1 virus, also known as avian flu.
Vaccine-maker Novavax said Friday it plans to sell 6.8 million shares of its stock.
Drug stocks cling to the flat line in morning activity while shares of Inovio Biomedical soar on positive clinical data for its new DNA-based flu vaccine.
New methods of studying avian influenza strains and visually mapping their movement around the world will help scientists more quickly learn the behavior of the pandemic H1N1 flu virus, researchers say.
CALGARY, Alberta -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Inovio Biomed Corp . Emerging Stock Report is currently offering a complimentary trial subscription to the investment community.
Fighting flu is the goal of a group of UT researchers who worry today's drugs won't pack the same punch tomorrow.
PROVIDENCE - Physicians should treat the high fever and dry cough of classic flu promptly with antiviral medications, whether or not patients test positive for H1N1, the virus which is making people sick in epidemic proportions.
DxNA, a molecular diagnostics company headquartered in St. George, Utah, announced today that the DxNA GeneSTAT PCR system has successfully completed evaluation studies under the direction of a California laboratory supported by the Joint FAO/IAEA Programme in Food and Agriculture.
Nov 18, 2009 (CIDRAP News) – Federal officials, along with representatives from four vaccine companies, appeared before two US House of Representatives committees today to answer questions about why the nation hasn't stretched scarce pandemic vaccine supply with adjuvants and if a more federally directed distribution system might help vaccine get to more high-risk patients.
It was only a matter of time. Last week a 13-year-old cat in Iowa had a confirmed case of swine flu. Now before you panic and kick kitty out of the house, let's take a calm, scientific look at the facts.
BEIJING, Nov. 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S.
In case you didn't tune into The Washington Times' nationally syndicated radio show, "America's Morning News" - heard in Washington on WTNT-AM 570 and coast-to-coast via the Talk Radio Network - here's what four of Tuesday's guests told co-hosts Melanie Morgan and John McCaslin: - Former Attorney General Michael B. Mukasey: Mr. Mukasey, a retired chief federal judge in New York, blasted his ...
Asia will receive a stockpile of 500,000 courses of H1N1 flu drugs by April next year to supplement any shortfall in the region, an official with a Japanese donor agency said on Tuesday.
CEL-SCI Corporation , a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today the start of the Company's first clinical study for hospitalized H1N1 patients at The Johns Hopkins University School of Medicine .
Medicago Inc. , a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles , today announced that Frederic Ors, VP Business Development will be presenting at the Influenza Congress USA 2009 on November 20, 2009 at 11:00 am at The Westin Washington, Washington, D.C.
AUSTIN, Texas----Asuragen, Inc. announced today that it has entered into an exclusive agreement with Life Technologies Corporation to develop and distribute worldwide an in-vitro diagnostic test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia .